Skip to main content

Black, White Cancer Patients Now Benefit Equally From Cord Blood Therapy

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 1, 2024.

By Carole Tanzer Miller HealthDay Reporter

TUESDAY, Oct. 1, 2024 -- Blood cancer patients of all races who receive cord blood transplants are now living longer.

The finding, reported by a team led by oncologist Dr. Karen Ballen, of UVA (University of Virginia) Health, shows that a previously identified survival gap for transplant recipients has been eliminated.

"Outcomes for cord blood transplants are improving for patients of all racial and ethnic backgrounds," Ballen said in a UVA news release.

The new study looked at more than 2,600 patients with blood cancer who received umbilical cord blood transplants between 2007 and 2017.

Black, Asian, Hispanic and white recipients survived equally well, the study found.

Still, cases of "graft-versus-host" disease -- a complication of cord blood transplantation that can lead to organ damage and severe infections -- was more common in Black children.

Cord blood cells restore the patient's ability to make blood cells after such cancer treatments as high-dose chemotherapy.

Though cord blood transplants are becoming less common in the United States, researchers said cord blood remains a vital lifeline for many patients. Because it needs not be precisely matched to the recipient, it is especially helpful for patients from racial or ethnic minority groups who often struggle to find a fully matched unrelated donor.

Researchers found that matching race was less important than the total number of cord blood cells transplanted.

"The more, the better," they said.

They cited several contributors to improved survival rates. Those included improved identification of appropriate patients, newer techniques for matching patients and donors, and better antibiotics and other care.

The findings are published in the October issue of the journal Transplantation and Cellular Therapy.

Sources

  • UVA Health, news release, Sept. 30, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted October 2024

Read this next

GLP-1 Weight-Loss Meds Could Interfere With Endoscopy, Colonoscopy

TUESDAY, Oct. 1, 2024 -- Food left in the stomach or stool left in the bowel can impede a doctor's ability to successfully perform an endoscopy or colonoscopy. Now, research...

Helene's Aftermath: How to Safely Enter, Clean Flood-Damaged Homes

TUESDAY, Oct. 1, 2024 -- Following the historic destruction of Hurricane Helene, many Americans must now return to their mangled homes and begin the heartbreaking task of...

Outpatient CAR-T Cancer Therapy Can Be Safe, Effective

TUESDAY, Oct. 1, 2024 -- Patients with fast-spreading blood cancer respond well to outpatient treatment with CAR-T therapy, the largest study examining its use in a community...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.